Society for Women's Health Research

Society for Women's Health Research Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Society for Women's Health Research, 1025 Connecticut Avenue NW, Ste 601, Washington D.C., DC.

SWHR is a national nonprofit dedicated to advancing women’s health through science, policy, and education while promoting research on sex differences to optimize women’s health. The Society for Women’s Health Research (SWHR),is the thought-leader in research on sex differences and is dedicated to improving women’s health through science, advocacy, and education. SWHR advocates for greater public a

nd private funding for women’s health research and the study of biological differences that affect the prevention, diagnosis and treatment of disease; encourages the appropriate inclusion of women and minorities in medical research studies; promotes the analysis of research data for sex and ethnic differences; and informs women, healthcare providers, and policy makers about contemporary women’s health issues through media outreach and periodic briefings, conferences and special events. As a result of SWHR’s work, women are now included in medical research and clinical trials and scientists are researching the ways in which health conditions and diseases affect men and women differently and why. Through its use of evidence-based research and multi-pronged policy and public education efforts, as well as the involvement of health care providers and policy makers dedicated to improving women’s health, women’s health is now a national priority.

What does Medicare cover when it comes to brain health? Created in partnership between HealthyWomen and Society for Wome...
06/17/2026

What does Medicare cover when it comes to brain health?

Created in partnership between HealthyWomen and Society for Women's Health Research, we’ve added a new chapter on women’s brain health to Savvy and 65: A Women’s Guide to Understanding Medicare.

This chapter explores mild cognitive impairment, Alzheimer's disease, dementia and Medicare benefits and services that may help you support your brain health as you age.

Download the free guide today.

https://medicareforwomen.org/brain-health/

This month, we are highlighting how to live well with  . Migraine is the  #2 cause of lost workdays. An estimated 113 mi...
06/17/2026

This month, we are highlighting how to live well with . Migraine is the #2 cause of lost workdays. An estimated 113 million workdays in the U.S. are lost to migraine annually.

To support those living with migraine, SWHR created the Migraine Patient Toolkit to help individuals find work wellness while living with migraine. Visit swhr.org to explore our free resource: https://swhr.org/resources/migraine-patient-toolkit-living-well-with-migraine/

June is Migraine & Headache Awareness Month! 16% of U.S. adults have reported experiencing   or severe  . And each perso...
06/17/2026

June is Migraine & Headache Awareness Month! 16% of U.S. adults have reported
experiencing or severe . And each person experiences migraine
differently. There are various migraine types and a wide range of symptoms that can occur.

Learn more and start your path to better days: migraineheadacheawarenessmonth.org/steps-to-care Coalition for Headache and Migraine Patients

 ? Three out of five autoimmune patients are women.  Previous evidence estimated that four out five of autoimmune patien...
06/16/2026

? Three out of five autoimmune patients are women.

Previous evidence estimated that four out five of autoimmune patients were women, but a 2024 study shows new disease prevalence for women is closer to 63%, 3 in 5.

Explore SWHR's new "Rare Autoimmune Disease in Women" fact sheet to learn more about rare diseases that impact women: https://ow.ly/ON8350Z88v0

Thank you to everyone who joined us yesterday in New Haven, CT at Yale for the collaborative symposium event, "From Disc...
06/16/2026

Thank you to everyone who joined us yesterday in New Haven, CT at Yale for the collaborative symposium event, "From Discovery to Impact: Accelerating Women’s Health Research Through Science, Policy, and Investment," hosted by SWHR and Women’s Health Research at Yale.

SWHR CEO Kathryn Schubert, MPP, CAE and Director of Women's Health Research at Yale Basmah Safdar, MD, MSc co-hosted the day.

The event brought together champions in women's health to discuss what's really needed to move the needle forward for women's health research. Conversations featured Nicole C. Kleinstreuer of the NIH, U.S. Congresswoman Rosa DeLauro (CT-3), Yale researchers, and reporters from The Lancet, STAT, The Wall Street Journal, and WSHU, among others.

See all of the day's speakers online here: https://swhr.org/event/from-discovery-to-impact-accelerating-womens-health-research-through-science-policy-and-investment/
Photo credit: Yale School of Medicine, Anthony DeCarlo

Join us this week at the SWHR x Autoimmunity & the Good Girls Book Event in Washington DC. Registration is free! https:/...
06/15/2026

Join us this week at the SWHR x Autoimmunity & the Good Girls Book Event in Washington DC. Registration is free! https://swhr.org/event/swhr-x-autoimmunity-the-good-girls-book-event/

SWHR CEO and President Kathryn Schubert will be in conversation with author Sara Hirsh Bordo, discussing Sara's new book "Autoimmunity & the Good Girls."

06/14/2026

We each have a unique skill we can bring to . How are you showing up as a women's health advocate?

Hear more from Sateria Venable, founder and CEO of The Fibroid Foundation and SWHR CEO Kathryn Schubert in this clip.

Get involved today and watch the full video at https://swhr.org/resources/advocating-for-womens-health-research-101/

This month, we are recognizing  . More than 60% of Alzheimer’s disease caregivers are women – many of whom are uncompens...
06/13/2026

This month, we are recognizing . More than 60% of Alzheimer’s disease caregivers are women – many of whom are uncompensated.

We need more holistic support for !

The SWHR policy agenda, Breaking Down the Burden of Alzheimer’s Disease, serve as a roadmap for key areas of policy change to improve outcomes for women - both as Alzheimer’s disease and . Read more today: https://swhr.org/resources/swhr-policy-agenda-breaking-down-the-burden-of-alzheimers-disease-for-women/

This June, share with SWHR who you support as a caregiver - and who supports you and your health!

We celebrated   on June 10 with a   webinar – but the importance of women's health research should be highlighted every ...
06/13/2026

We celebrated on June 10 with a webinar – but the importance of women's health research should be highlighted every day!

"My mind goes back to the patient. If the patient is not at the center, beginning, and end of the whole process, then we miss what were doing it all for," said Sabrena Mervin-Blake with Clinical Trials Transformation Initiative.

"If we don't have healthy people, we don't have healthy companies, and if we don't have healthy companies, we don't have a healthy America," said Mary McGowan with Foundation for Sarcoidosis Research.

“The obstacles for women are pretty extensive, in my opinion, for getting into clinical trials,” said Charise Van Liew, WomenHeart Champion and patient advocate. WomenHeart: The National Coalition for Women with Heart Disease

Did you miss our webinar conversation? Check out the full recording online here: https://swhr.org/event/advancing-womens-participation-in-clinical-trials-barriers-innovations-and-actionable-solutions/

Have you heard? Polyendocrine Metabolic Ovarian Syndrome   is the new name for the condition previously known as Polycys...
06/12/2026

Have you heard? Polyendocrine Metabolic Ovarian Syndrome is the new name for the condition previously known as Polycystic O***y Syndrome (PCOS) — a change that accurately reflects the condition, which affects 1 in 8 women, or more than 170 million worldwide.

The changes follows 14 years of research and advocacy and is the largest global engagement ever for a medical name change.

The term PCOS focused on “cysts” and ovaries. PMOS is a long term endocrine/ hormonal and metabolic condition, and the misunderstanding has contributed to delayed diagnosis, poor quality of care and lack of research and funding.

The change to PMOS will improve understanding, diagnosis, care, and research. Read the article in The Lancet to learn more: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext. SWHR PCOS Working Group member Anuja Dorkas is an author of this article.

There is a 3 year transition period where both names will co-exist together.

Learn more about from SWHR at https://swhr.org/health_focus_area/polycystic-ovary-syndrome/

Address

1025 Connecticut Avenue NW, Ste 601
Washington D.C., DC
20036

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Society for Women's Health Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share